Preventing the Development of Varices in Cirrhosis
- 1 November 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 41 (Supplement) , S300-S304
Abstract
Gastroesophageal varices are a direct consequence of portal hypertension. Nonselective beta-adrenergic blockers decrease portal pressure and are effective in preventing variceal hemorrhage. However, a large multicenter placebo-controlled trial demonstrates that nonselective beta-adrenergic blockers are not effective in preventing the development of varices and are associated with a significant rate of adverse events. This therapy is, therefore, not recommended in compensated cirrhotic patients without varices at large. In this very compensated group of patients with cirrhosis (stage 1, ie, without varices and without ascites or encephalopathy) the predictive value (both for the development of varices and for the development of clinical decompensation) of a baseline hepatic venous pressure gradient greater than 10 mm Hg is confirmed, supporting this threshold level as one that defines a clinically significant portal hypertension. Importantly, reductions in hepatic venous pressure gradient >10% are associated with a significant reduction in the development of varices, a therapeutic goal that could be achieved through the use of beta-blockers or other drugs being developed for the treatment of portal hypertension.Keywords
This publication has 31 references indexed in Scilit:
- The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisGastrointestinal Endoscopy, 2006
- The hepatic venous pressure gradient: Anything worth doing should be done rightHepatology, 2004
- Incidence and natural history of small esophageal varices in cirrhotic patientsJournal of Hepatology, 2003
- Nitric Oxide and Portal Hypertension: Its Role in the Regulation of Intrahepatic and Splanchnic Vascular ResistanceSeminars in Liver Disease, 1999
- Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic ratsHepatology, 1998
- Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findingsGastroenterology, 1998
- Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?Journal of Hepatology, 1992
- Portal hypertension in primary biliary cirrhosisJournal of Hepatology, 1987
- Portal Pressure, Presence of Gastroesophageal Varices and Variceal BleedingHepatology, 1985
- Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilatorsJournal of Hepatology, 1985